The proportion of diagnoses in the emergency setting and waiting times showed increasing trends ( n = 8, 89% and n = 14, 56%, respectively). A reduction was also observed in the number of diagnostic procedures ( n = 64, 58%) and diagnoses ( n = 130, 89%). Indicators assessing the diagnostic process showed a decreasing trend: from 33 indicators reporting on screening, 30 (91%) signalled a decrease during the pandemic ( n = 30 indicators, 91%). This study included 135 articles, from which 1013 indicators were retrieved. Performance indicators and their trends were collated according to the cancer care pathway. Search conducted in MEDLINE and Embase databases. This study aims to summarize performance indicators used in the literature to evaluate the impact of the COVID-19 pandemic on cancer care (January-June 2020) in OECD countries and to assess changes in the quality of care as reported via selected indicators. Assessing the changes in the quality of cancer care during the COVID-19 pandemic requires a structured approach considering the high volume of publications. However, the development of process and cancer-pathway based information is essential to guide health care delivery, allowing for better monitoring of changes in the quality of care provided. Performance indicators monitoring cancer outcomes are routinely used in OECD countries. ![]() Cancer comprises a high burden on health systems.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |